![Peter Wolfe](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 13 $ al 31/07/2026
Peter Wolfe is currently Chief Financial Officer & Secretary at ZyVersa Therapeutics, Inc., a position held since 2022.
Education history includes an MBA from the University of Pittsburgh and an undergraduate degree from the University of Miami.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 11/07/2025 | 127 ( 0 % ) | 13 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ZYVERSA THERAPEUTICS, INC. | Director Financiero/CFO | 12/12/2022 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
University of Pittsburgh
 University of Pittsburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Miami
 University of Miami Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ZyVersa Therapeutics, Inc.
 ZyVersa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops product candidates in the areas of renal and inflammatory diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
